Preconditioning suppresses inflammation in neonatal hypoxic ischemia via Akt activation

Stroke

Volumn 38, Issue 3, 2007, Pages 1017-1024

  Yin, Wei ^a   Signore, Armando P ^a   Iwai, Masanori ^a   Cao, Guodong ^a,b   Gao, Yanqin ^b   Johnnides, Michael J ^a   Hickey, Robert W ^a,c   Chen, Jun ^a,b,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Hypoxia ischemia; Inflammation; Neonatal; p Akt; Preconditioning

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BACTERIUM LIPOPOLYSACCHARIDE; CD68 ANTIGEN; CYCLOOXYGENASE 2; CYTOKINE; GLYCOGEN SYNTHASE KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOPEROXIDASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN NECROSIS; CAROTID ARTERY LIGATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; INFLAMMATION; ISCHEMIC PRECONDITIONING; MICROGLIA; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; RAT; SIGNAL TRANSDUCTION; TISSUE INJURY; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; ENZYMOLOGY; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANIMALS, NEWBORN; ENZYME ACTIVATION; HYPOXIA-ISCHEMIA, BRAIN; INFLAMMATION; ISCHEMIC PRECONDITIONING; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 33947494524     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000258102.18836.ca     Document Type: Article

References (28)

1. Benjelloun N, Renolleau S, Represa A, Ben-Ari Y, Charriaut-Marlangue C. Inflammatory responses in the cerebral cortex after ischemia in the p7 neonatal rat. Stroke. 1999;30:1916-1923.
2. Barone FC, and Feuerstein GZ. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab. 1999;19:819-834.
3. del Zoppo G, Ginis I, Hallenbeck J. M., Iadecola C, Wang X, Feuerstein GZ. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol. 2000;10:95-112.
4. Gidday JM, Fitzgibbons JC, Shah AR, Park TS. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett. 1994;168:221-224.
5. Ran R, Xu H, Lu A, Bernaudin M, Sharp FR. Hypoxia preconditioning in the brain. Dev Neurosci. 2005;27:87-92.
6. Perez-Pinzon MA, Xu GP, Dietrich WD, Rosenthal M, Sick TJ. Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global ischemia. J Cereb Blood Flow Metab. 1997;17:175-182.
7. Yano S, Morioka M, Fukunaga K, Kawano T, Hara T, Kai Y, Hamada J, Miyamoto E, Ushio Y. Activation of akt/protein kinase b contributes to induction of ischemic tolerance in the ca1 subfield of gerbil hippocampus. J Cereb Blood Flow Metab. 2001;21:351-360.
8. Wick A, Wick W, Waltenberger J, Weller M, Dichgans J, Schulz JB. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and akt. J Neurosci. 2002;22:6401-6407.
9. Guha M, Mackman N. The phosphatidylinositol 3-kinase-akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem. 2002;277:32124-32132.
10. Liu J, Narasimhan P, Yu FS, Chan PH. Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin. Stroke. 2005;36:1264-1269.
11. Jones NM, Bergeron M. Hypoxia-induced ischemic tolerance in neonatal rat brain involves enhanced erk1/2 signaling. J Neurochem. 2004;89:157-167.
12. Rice JE, Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol. 1981;9:131-141.
13. Adachi M, Sohma O, Tsuneishi S, Takada S, Nakamura H. Combination effect of systemic hypothermia and caspase inhibitor administration against hypoxic-ischemic brain damage in neonatal rats. Pediatr Res. 2001;50:590-595.
14. Cheng Y, Gidday JM, Yan Q, Shah AR, Holtzman DM. Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury. Ann Neurol. 1997;41:521-529.
15. Bergeron M, Evans SM, Sharp FR, Koch CJ, Lord EM, Ferriero DM. Detection of hypoxic cells with the 2-nitroimidazole, ef5, correlates with early redox changes in rat brain after perinatal hypoxia-ischemia. Neuroscience. 1999;89:1357-1366.
16. Yin W, Cao GD, Johnnides MJ, Signore AP, Luo YM, Hickey RW, Chen J. Tat-mediated delivery of bcl-xl protein is neuroprotective against neonatal hypoxic-ischemic brain injury via inhibition of caspases and aif. Neurobiol Dis. 2006;21:358-371.
17. Lin S, Rhodes PG, Lei M, Zhang F, Cai Z. alpha-Phenyl-N-tert- butyl-nitrone attenuates hypoxic-ischemic white matter injury in the neonatal rat brain. Brain Res. 2004;1007:132-141.
18. Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3 beta in cellular signaling. Prog Neurobiol. 2001;65:497.
19. Hudome S, Palmer C, Roberts RL, Mauger D, Housman C, Towfighi J. The role of neutrophils in the production of hypoxic ischemic brain injury in the neonatal rat. Pediatr Res. 1997;41:607-616.
20. Milatovic D, Zaja-Milatovic S, Montine KS, Horner PJ, Montine TJ. Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum. J Neurochem. 2003;87:1518-1526.
21. Kariko K, Weissman D, Welsh FA. Inhibition of toll-like receptor and cytokine signaling-a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab. 2004;24:1288-1304.
22. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR. Requirement for glycogen synthase kinase-3beta in cell survival and Nf-kappab activation. Nature. 2000;406:86-90.
23. Steinbrecher KA, Wilson W, Cogswell PC, Baldwin AS. Glycogen synthase kinase 3 beta functions to specify gene-specific, nf-kappa b-dependent transcription. Mol Cell Biol. 2005;25:8444-8455.
24. Grimes CA, Jope RS. Creb DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem. 2001;78:1219-1232.
25. De Jong EK, Dijkstra IM, Hensens M, Brouwer N, van Amerongen M, Liem RS, Boddeke HW, Biber K. Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion. J Neurosci. 2005;25:7548-7557.
26. Lee HT, Chang YC, Wang LY, Wang ST, Huang CC, Ho CJ. Camp response element-binding protein activation in ligation preconditioning in neonatal brain. Ann Neurol. 2004;56:611-623.
27. Zhu C, Xu F, Wang X, Shibata M, Uchiyama Y, Blomgren K, Hagberg H. Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia-ischaemia. J Neurochem. 2006;96:1016-1027.
28. Hagberg H, Wilson MA, Matsushita H, Zhu C, Lange M, Gustavsson M, Poitras MF, Dawson TM, Dawson VL, Northington F, Johnston MV. PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. J Neurochem. 2004;90:1068-1075.